Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice

Oncogenesis

Volumn 1, Issue 9, 2012, Pages

  Xiong, X ^a   Chorzalska, A ^a   Dubielecka, P M ^a,e   White, J R ^b   Vedvyas, Y ^a   Hedvat, C V ^b   Haimovitz Friedman, A ^b   Koutcher, J A ^b   Reimand, J ^c   Bader, G D ^d   Sawicki, J A ^e   Kotula, L ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abi1; gene mutations; Hssh3bp1; mouse model; prostate cancer

Indexed keywords

BETA CATENIN; CRE RECOMBINASE; PROTEIN KINASE B; UVOMORULIN;

ABI1 GENE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE DISRUPTION; GENE EXPRESSION; GENETIC COMPLEMENTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UPREGULATION;

MUS;

EID: 84868284582     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2012.28     Document Type: Article

References (41)

1. Yu W, Sun X, Clough N, Cobos E, Tao Y, Dai Z. Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo. Carcinogenesis 2008; 29: 1717-1724.
2. Wang C, Tran-Thanh D, Moreno JC, Cawthorn TR, Jacks LM, Wang DY et al. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation. Breast Cancer Res Treat 2011; 129: 373-386.
3. Cui M, Yu W, Dong J, Chen J, Zhang X, Liu Y. Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma. Med Oncol 2010; 27: 632-639.
4. Macoska JA, Xu J, Ziemnicka D, Schwab TS, Rubin MA, Kotula L. Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma. Neoplasia 2001; 3: 99-104. (Pubitemid 32410349)
5. Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim KS, Jenkins EC et al. Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J Biol Chem 1998; 273: 13681-13692. (Pubitemid 28268415)
6. Xiong X, Cui P, Hossain S, Xu R, Warner B, Guo X et al. Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1. Biochimica et Biophysica Acta 2008; 1783: 737-747.
7. Dubielecka PM, Machida K, Xiong X, Hossain S, Ogiue-Ikeda M, Carrera AC et al. Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells. FEBS Lett 2010; 584: 3279-3286.
8. Jia S, Roberts TM, Zhao JJ. Should individual PI3 kinase isoforms be targeted in cancer? Curr Opin Cell Biol 2009; 21: 199-208.
9. Eden S, Rohatgi R, AV Podtelejnikov, Mann M, Kirschner MW. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 2002; 418: 790-793.
10. Stradal TE, Rottner K, Disanza A, Confalonieri S, Innocenti M, Scita G. Regulation of actin dynamics by WASP and WAVE family proteins. Tr Cell Biol 2004; 14: 303-311. (Pubitemid 38798179)
11. Dubielecka PM, Ladwein KI, Xiong X, Migeotte I, Chorzalska A, Anderson KV et al. Essential role for Abi1 in embryonic survival and WAVE2 complex integrity. Proc Natl Acad Sci USA 2011; 108: 7022-7027.
12. Lebensohn AM, Kirschner MW. Activation of the WAVE complex by coincident signals controls actin assembly. Mol Cell 2009; 36: 512-524.
13. Yamazaki D, Oikawa T, Takenawa T. Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion. J Cell Sci 2007; 120(Pt 1): 86-100. (Pubitemid 46206652)
14. Ryu JR, Echarri A, Li R, Pendergast AM. Regulation of cell-cell adhesion by Abi/Diaphanous complexes. Mol Cell Biol 2009; 29: 1735-1748.
15. Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y et al. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell 2009; 137: 1047-1061.
16. Fernando HS, Sanders AJ, Kynaston HG, Jiang WG. WAVE1 is associated with invasiveness and growth of prostate cancer cells. J Urol 2008; 180: 1515-1521.
17. Fernando HS, Sanders AJ, Kynaston HG, Jiang WG. WAVE3 is associated with invasiveness in prostate cancer cells. Urol Oncol 2010; 28: 320-327.
18. Innocenti M, Gerboth S, Rottner K, Lai FP, Hertzog M, Stradal TE et al. Abi1 regulates the activity of N-WASP and WAVE in distinct actin-based processes. Nat Cell Biol 2005; 7: 969-976. (Pubitemid 41486270)
19. Dai Z, Pendergast AM. Abi-2 a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev 1995; 9: 2569-2582.
20. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G et al. ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell 2011; 41: 661-671.
21. Dubielecka PM, Cui P, Xiong X, Hossain S, Heck S, Angelov L et al. Differential regulation of macropinocytosis by Abi1/Hssh3bp1 isoforms. PloS One 2010; 5: e10430.
22. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004; 64: 2270-2305.
23. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470: 214-220.
24. Kumar A, White TA, MacKenzie AP, Clegg N, Lee C, Dumpit RF et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci USA 2011; 108: 17087-17092.
25. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068.
26. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333: 1157-1160.
27. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16: 1414-1420.
28. Luo J, Cantley LC. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. Cell Cycle 2005; 4: 1309-1312. (Pubitemid 41437108)
29. Jimenez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstrom S et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 1998; 17: 743-753. (Pubitemid 28062053)
30. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH et al. The phosphatidylinositol 30-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 2001; 61: 7426-7429. (Pubitemid 32995029)
31. Wang F. Modeling human prostate cancer in genetically engineered mice. Prog Mol Biol Trans Sci 2011; 100: 1-49.
32. Abate-Shen C. A new generation of mouse models of cancer for translational research. Clin Cancer Res 2006; 12: 5274-5276. (Pubitemid 44497239)
33. Kasper S. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis. J Cell Biochem 2005; 94: 279-297. (Pubitemid 41420307)
34. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA et al. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 2002; 22: 1495-1503. (Pubitemid 34150785)
35. Kelavkar UP, Parwani AV, Shappell SB, Martin WD. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 2006; 8: 510-522. (Pubitemid 44035335)
36. Pearson HB, Phesse TJ, AR Clarke. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse. Cancer Res 2009; 69: 94-101.
37. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A et al. Pten dose dictates cancer progression in the prostate. PLoS Biol 2003; 1: E59.
38. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992; 84: 951-957.
39. Garzotto M, Haimovitz-Friedman A, Liao WC, White-Jones M, Huryk R, Heston WD et al. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 1999; 59: 5194-5201. (Pubitemid 29503982)
40. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P et al. Abelson-interactor-promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad Sci USA 2005; 102: 1098-1103. (Pubitemid 40170732)
41. Echarri A, Lai MJ, Robinson MR, Pendergast AM. Abl interactor 1 (Abi-1) wavebinding and SNARE domains regulate its nucleocytoplasmic shuttling, lamellipodium localization, and wave-1 levels. Mol Cell Biol 2004; 24: 4979-4993. (Pubitemid 38668061)